|
G |
Akt1 |
AKT serine/threonine kinase 1 |
multiple interactions |
ISO |
usnic acid results in decreased phosphorylation of and results in decreased expression of AKT1 protein |
CTD |
PMID:25078063 |
|
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
|
|
G |
Atf4 |
activating transcription factor 4 |
multiple interactions increases expression |
ISO |
2-aminoethoxydiphenyl borate inhibits the reaction [usnic acid results in increased expression of ATF4 protein] |
CTD |
PMID:25870318 |
|
NCBI chr 7:111,804,135...111,806,457
Ensembl chr 7:111,804,183...111,806,446
|
|
G |
Atm |
ATM serine/threonine kinase |
increases phosphorylation multiple interactions |
ISO |
usnic acid results in increased phosphorylation of ATM protein Acetylcysteine inhibits the reaction [usnic acid results in increased phosphorylation of ATM protein] |
CTD |
PMID:31715134 |
|
NCBI chr 8:53,828,741...53,932,773
Ensembl chr 8:53,831,093...53,932,437
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
decreases expression increases expression |
ISO |
usnic acid results in decreased expression of BAX protein usnic acid results in increased expression of BAX protein |
CTD |
PMID:22285236 PMID:31715134 |
|
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
decreases expression |
ISO |
usnic acid results in decreased expression of BCL2 protein |
CTD |
PMID:22285236 PMID:25078063 PMID:31715134 |
|
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Casp3 |
caspase 3 |
multiple interactions increases activity |
ISO |
3-methyladenine promotes the reaction [usnic acid results in increased activity of CASP3 protein]; 4-phenylbutyric acid inhibits the reaction [usnic acid results in increased activity of CASP3 protein]; Chloroquine promotes the reaction [usnic acid results in increased activity of CASP3 protein]; pyrazolanthrone promotes the reaction [usnic acid results in increased activity of CASP3 protein] |
CTD |
PMID:22285236 PMID:25078063 PMID:25870318 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp4 |
caspase 4 |
increases cleavage |
ISO |
usnic acid results in increased cleavage of CASP4 protein |
CTD |
PMID:25870318 |
|
NCBI chr 8:2,599,017...2,635,097
Ensembl chr 8:2,598,876...2,635,092
|
|
G |
Casp7 |
caspase 7 |
multiple interactions increases activity |
ISO |
3-methyladenine promotes the reaction [usnic acid results in increased activity of CASP7 protein]; 4-phenylbutyric acid inhibits the reaction [usnic acid results in increased activity of CASP7 protein]; Chloroquine promotes the reaction [usnic acid results in increased activity of CASP7 protein]; pyrazolanthrone promotes the reaction [usnic acid results in increased activity of CASP7 protein] |
CTD |
PMID:25078063 PMID:25870318 |
|
NCBI chr 1:255,437,438...255,476,737
Ensembl chr 1:255,437,172...255,476,729
|
|
G |
Cat |
catalase |
multiple interactions |
EXP |
usnic acid inhibits the reaction [Indomethacin results in increased activity of CAT protein] |
CTD |
PMID:16169175 |
|
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
|
|
G |
Ccl21 |
C-C motif chemokine ligand 21 |
multiple interactions increases expression |
ISO |
[usnic acid co-treated with Lipopolysaccharides] results in increased expression of CCL21 mRNA usnic acid results in increased expression of CCL21 mRNA |
CTD |
PMID:21953288 PMID:22777745 |
|
NCBI chr 5:56,980,557...56,981,661
Ensembl chr 5:56,980,558...56,981,686
|
|
G |
Ccl4 |
C-C motif chemokine ligand 4 |
multiple interactions |
ISO |
[usnic acid co-treated with Lipopolysaccharides] results in increased expression of CCL4 mRNA |
CTD |
PMID:22777745 |
|
NCBI chr10:68,466,394...68,468,229
Ensembl chr10:68,452,052...68,468,231
|
|
G |
Ccnc |
cyclin C |
multiple interactions increases expression |
ISO |
[usnic acid co-treated with Lipopolysaccharides] results in decreased expression of CCNC mRNA usnic acid results in increased expression of CCNC mRNA |
CTD |
PMID:21953288 PMID:22777745 |
|
NCBI chr 5:35,266,828...35,284,943
Ensembl chr 5:35,266,823...35,296,584
|
|
G |
Ccnd1 |
cyclin D1 |
decreases expression |
ISO |
usnic acid results in decreased expression of CCND1 protein |
CTD |
PMID:27369375 |
|
NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
|
|
G |
Ccnd3 |
cyclin D3 |
decreases expression |
ISO |
usnic acid results in decreased expression of CCND3 protein |
CTD |
PMID:27369375 |
|
NCBI chr 9:13,394,161...13,400,341
Ensembl chr 9:13,394,169...13,489,371
|
|
G |
Cdk2 |
cyclin dependent kinase 2 |
decreases expression |
ISO |
usnic acid results in decreased expression of CDK2 protein |
CTD |
PMID:27369375 |
|
NCBI chr 7:1,129,878...1,137,431
Ensembl chr 7:1,129,811...1,137,403
|
|
G |
Cdk4 |
cyclin-dependent kinase 4 |
decreases expression |
ISO |
usnic acid results in decreased expression of CDK4 protein |
CTD |
PMID:27369375 |
|
NCBI chr 7:62,886,124...62,889,562
Ensembl chr 7:62,883,105...62,942,403
|
|
G |
Cdk6 |
cyclin-dependent kinase 6 |
decreases expression |
ISO |
usnic acid results in decreased expression of CDK6 protein |
CTD |
PMID:27369375 |
|
NCBI chr 4:30,637,650...30,829,688
Ensembl chr 4:30,646,460...30,829,634
|
|
G |
Chek1 |
checkpoint kinase 1 |
increases expression |
ISO |
usnic acid results in increased expression of CHEK1 protein modified form |
CTD |
PMID:27369375 |
|
NCBI chr 8:36,420,565...36,443,477
Ensembl chr 8:36,420,569...36,441,009
|
|
G |
Chek2 |
checkpoint kinase 2 |
increases expression multiple interactions |
ISO |
usnic acid results in increased expression of CHEK2 protein; usnic acid results in increased expression of CHEK2 protein modified form Acetylcysteine inhibits the reaction [usnic acid results in increased expression of CHEK2 protein] |
CTD |
PMID:27369375 PMID:31715134 |
|
NCBI chr12:45,788,823...45,821,382
Ensembl chr12:45,788,827...45,821,286
|
|
G |
Cryab |
crystallin, alpha B |
multiple interactions |
ISO |
[usnic acid co-treated with Lipopolysaccharides] results in decreased expression of CRYAB mRNA |
CTD |
PMID:22777745 |
|
NCBI chr 8:51,093,441...51,099,161
Ensembl chr 8:51,093,441...51,099,157
|
|
G |
Csf2 |
colony stimulating factor 2 |
multiple interactions decreases expression |
ISO |
[usnic acid co-treated with Lipopolysaccharides] results in decreased expression of CSF2 mRNA usnic acid results in decreased expression of CSF2 mRNA |
CTD |
PMID:21953288 PMID:22777745 |
|
NCBI chr10:38,386,945...38,388,926
Ensembl chr10:38,386,945...38,389,199
|
|
G |
Cxcl10 |
C-X-C motif chemokine ligand 10 |
multiple interactions |
ISO |
[usnic acid co-treated with Lipopolysaccharides] results in decreased expression of CXCL10 mRNA |
CTD |
PMID:22777745 |
|
NCBI chr14:15,704,772...15,706,969
Ensembl chr14:15,704,758...15,706,975
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
decreases expression |
ISO |
usnic acid results in decreased expression of CYP1A1 mRNA |
CTD |
PMID:21953288 |
|
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
|
|
G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
multiple interactions decreases expression |
ISO |
[usnic acid co-treated with Lipopolysaccharides] results in decreased expression of CYP2E1 mRNA usnic acid results in decreased expression of CYP2E1 mRNA |
CTD |
PMID:21953288 PMID:22777745 |
|
NCBI chr 1:195,840,330...195,850,728
Ensembl chr 1:195,840,058...195,864,023
|
|
G |
Cyp7a1 |
cytochrome P450 family 7 subfamily A member 1 |
multiple interactions |
ISO |
[usnic acid co-treated with Lipopolysaccharides] results in decreased expression of CYP7A1 mRNA |
CTD |
PMID:22777745 |
|
NCBI chr 5:19,376,979...19,386,676
Ensembl chr 5:19,376,974...19,386,688
|
|
G |
Ddb1 |
damage-specific DNA binding protein 1 |
multiple interactions |
ISO |
[usnic acid co-treated with Lipopolysaccharides] results in decreased expression of DDB1 mRNA |
CTD |
PMID:22777745 |
|
NCBI chr 1:207,252,890...207,278,685
Ensembl chr 1:207,252,890...207,278,676
|
|
G |
Ddit3 |
DNA-damage inducible transcript 3 |
multiple interactions increases expression |
ISO |
2-aminoethoxydiphenyl borate inhibits the reaction [usnic acid results in increased expression of DDIT3 protein] usnic acid results in increased expression of DDIT3 mRNA; usnic acid results in increased expression of DDIT3 protein |
CTD |
PMID:25870318 |
|
NCBI chr 7:63,115,645...63,121,203
Ensembl chr 7:63,116,380...63,121,201
|
|
G |
Eif4ebp1 |
eukaryotic translation initiation factor 4E binding protein 1 |
decreases phosphorylation |
ISO |
usnic acid results in decreased phosphorylation of EIF4EBP1 protein |
CTD |
PMID:25078063 |
|
NCBI chr16:64,792,595...64,805,984
Ensembl chr16:64,790,226...64,805,984
|
|
G |
Ercc1 |
ERCC excision repair 1, endonuclease non-catalytic subunit |
multiple interactions |
ISO |
[usnic acid co-treated with Lipopolysaccharides] results in decreased expression of ERCC1 mRNA |
CTD |
PMID:22777745 |
|
NCBI chr 1:78,971,310...79,007,963
Ensembl chr 1:78,996,390...79,007,963
|
|
G |
Faslg |
Fas ligand |
multiple interactions |
ISO |
[usnic acid co-treated with Lipopolysaccharides] results in decreased expression of FASLG mRNA |
CTD |
PMID:22777745 |
|
NCBI chr13:74,151,519...74,172,760
Ensembl chr13:74,154,954...74,162,215
|
|
G |
Fmo1 |
flavin containing dimethylaniline monoxygenase 1 |
multiple interactions |
ISO |
[usnic acid co-treated with Lipopolysaccharides] results in decreased expression of FMO1 mRNA |
CTD |
PMID:22777745 |
|
NCBI chr13:75,182,184...75,214,439
Ensembl chr13:75,182,176...75,214,647
|
|
G |
Gclc |
glutamate-cysteine ligase, catalytic subunit |
multiple interactions increases expression |
ISO |
NFE2L2 protein promotes the reaction [usnic acid results in increased expression of GCLC protein] usnic acid results in increased expression of GCLC mRNA; usnic acid results in increased expression of GCLC protein |
CTD |
PMID:27369375 |
|
NCBI chr 8:78,629,899...78,668,547
Ensembl chr 8:78,630,127...78,668,544
|
|
G |
Gpx1 |
glutathione peroxidase 1 |
multiple interactions |
ISO |
[usnic acid co-treated with Lipopolysaccharides] results in increased expression of GPX1 mRNA |
CTD |
PMID:22777745 |
|
NCBI chr 8:109,026,905...109,028,031
Ensembl chr 8:109,026,905...109,028,024
|
|
G |
Gsr |
glutathione-disulfide reductase |
multiple interactions increases expression |
ISO |
[usnic acid co-treated with Lipopolysaccharides] results in increased expression of GSR mRNA usnic acid results in increased expression of GSR protein |
CTD |
PMID:22777745 PMID:27369375 |
|
NCBI chr16:58,482,209...58,525,256
Ensembl chr16:58,482,505...58,525,661
|
|
G |
Gsta1 |
glutathione S-transferase alpha 1 |
increases expression |
ISO |
usnic acid results in increased expression of GSTA1 protein |
CTD |
PMID:27369375 |
|
NCBI chr 9:23,703,476...23,720,121
Ensembl chr 9:23,703,477...23,720,121
|
|
G |
H2ax |
H2A.X variant histone |
increases expression multiple interactions |
ISO |
usnic acid results in increased expression of H2AX protein; usnic acid results in increased expression of H2AX protein modified form Acetylcysteine inhibits the reaction [usnic acid results in increased expression of H2AX protein]; NFE2L2 protein inhibits the reaction [usnic acid results in increased expression of H2AX protein modified form] |
CTD |
PMID:27369375 PMID:31715134 |
|
NCBI chr 8:44,671,907...44,673,262
Ensembl chr 8:44,671,786...44,673,239
|
|
G |
Hsp90ab1 |
heat shock protein 90 alpha family class B member 1 |
multiple interactions |
ISO |
[usnic acid co-treated with Lipopolysaccharides] results in decreased expression of HSP90AB1 mRNA |
CTD |
PMID:22777745 |
|
NCBI chr 9:15,432,986...15,438,358
Ensembl chr 9:15,433,691...15,438,488
|
|
G |
Hspa1a |
heat shock protein family A (Hsp70) member 1A |
multiple interactions |
ISO |
[usnic acid co-treated with Lipopolysaccharides] results in increased expression of HSPA1A mRNA |
CTD |
PMID:22777745 |
|
NCBI chr20:3,870,765...3,873,221
Ensembl chr20:3,856,006...3,873,227
|
|
G |
Hspa2 |
heat shock protein family A (Hsp70) member 2 |
multiple interactions |
ISO |
[usnic acid co-treated with Lipopolysaccharides] results in decreased expression of HSPA2 mRNA |
CTD |
PMID:22777745 |
|
NCBI chr 6:95,128,504...95,131,281
Ensembl chr 6:95,128,350...95,131,287
|
|
G |
Hspa5 |
heat shock protein family A (Hsp70) member 5 |
multiple interactions |
ISO |
[usnic acid co-treated with Lipopolysaccharides] results in decreased expression of HSPA5 mRNA |
CTD |
PMID:22777745 |
|
NCBI chr 3:18,055,507...18,059,969
Ensembl chr 3:18,055,405...18,059,891
|
|
G |
Hsph1 |
heat shock protein family H (Hsp110) member 1 |
multiple interactions |
ISO |
[usnic acid co-treated with Lipopolysaccharides] results in increased expression of HSPH1 mRNA |
CTD |
PMID:22777745 |
|
NCBI chr12:5,390,916...5,410,224
Ensembl chr12:5,390,922...5,410,224
|
|
G |
Il18 |
interleukin 18 |
multiple interactions |
ISO |
[usnic acid co-treated with Lipopolysaccharides] results in increased expression of IL18 mRNA |
CTD |
PMID:22777745 |
|
NCBI chr 8:50,904,630...50,932,887
Ensembl chr 8:50,906,960...50,932,887
|
|
G |
Il1a |
interleukin 1 alpha |
multiple interactions |
ISO |
[usnic acid co-treated with Lipopolysaccharides] results in decreased expression of IL1A mRNA |
CTD |
PMID:22777745 |
|
NCBI chr 3:116,526,601...116,537,055
Ensembl chr 3:116,526,604...116,536,822
|
|
G |
Il1b |
interleukin 1 beta |
multiple interactions |
ISO |
[usnic acid co-treated with Lipopolysaccharides] results in decreased expression of IL1B mRNA |
CTD |
PMID:22777745 |
|
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Il6 |
interleukin 6 |
multiple interactions |
ISO |
[usnic acid co-treated with Lipopolysaccharides] results in decreased expression of IL6 mRNA |
CTD |
PMID:22777745 |
|
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Lta |
lymphotoxin alpha |
multiple interactions |
ISO |
[usnic acid co-treated with Lipopolysaccharides] results in decreased expression of LTA mRNA |
CTD |
PMID:22777745 |
|
NCBI chr20:3,618,853...3,621,324
Ensembl chr20:3,618,853...3,620,859
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
increases phosphorylation |
ISO |
usnic acid results in increased phosphorylation of MAPK1 protein |
CTD |
PMID:25078063 |
|
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
increases phosphorylation |
ISO |
usnic acid results in increased phosphorylation of MAPK3 protein |
CTD |
PMID:25078063 |
|
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
|
|
G |
Mcl1 |
MCL1 apoptosis regulator, BCL2 family member |
multiple interactions decreases expression |
ISO |
3-methyladenine promotes the reaction [usnic acid results in decreased expression of MCL1 protein]; Chloroquine promotes the reaction [usnic acid results in decreased expression of MCL1 protein]; pyrazolanthrone promotes the reaction [usnic acid results in decreased expression of MCL1 protein] |
CTD |
PMID:25078063 |
|
NCBI chr 2:183,219,137...183,235,676
Ensembl chr 2:183,219,220...183,222,303
|
|
G |
Mpo |
myeloperoxidase |
multiple interactions |
EXP |
usnic acid inhibits the reaction [Indomethacin results in increased activity of MPO protein] |
CTD |
PMID:16169175 |
|
NCBI chr10:72,594,883...72,608,862
Ensembl chr10:72,594,661...72,604,819
|
|
G |
Mtor |
mechanistic target of rapamycin kinase |
multiple interactions |
ISO |
usnic acid results in decreased phosphorylation of and results in decreased expression of MTOR protein |
CTD |
PMID:25078063 |
|
NCBI chr 5:158,884,856...158,994,311
Ensembl chr 5:158,884,804...158,994,311
|
|
G |
Nfe2l2 |
NFE2 like bZIP transcription factor 2 |
multiple interactions |
ISO |
NFE2L2 protein inhibits the reaction [usnic acid results in increased expression of H2AX protein modified form]; NFE2L2 protein promotes the reaction [usnic acid results in increased expression of GCLC protein]; usnic acid results in increased expression of and affects the localization of NFE2L2 protein |
CTD |
PMID:27369375 |
|
NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
|
|
G |
Nos2 |
nitric oxide synthase 2 |
multiple interactions |
ISO EXP |
[usnic acid co-treated with Lipopolysaccharides] results in decreased expression of NOS2 mRNA usnic acid inhibits the reaction [Indomethacin results in increased activity of NOS2 protein] |
CTD |
PMID:16169175 PMID:22777745 |
|
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
|
|
G |
Nqo1 |
NAD(P)H quinone dehydrogenase 1 |
increases expression |
ISO |
usnic acid results in increased expression of NQO1 protein |
CTD |
PMID:27369375 |
|
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
|
|
G |
Orai1 |
ORAI calcium release-activated calcium modulator 1 |
increases expression multiple interactions |
ISO EXP |
usnic acid results in increased expression of ORAI1 protein 2-aminoethoxydiphenyl borate inhibits the reaction [usnic acid results in increased expression of ORAI1 protein] |
CTD |
PMID:25870318 |
|
NCBI chr12:33,533,151...33,548,361
Ensembl chr12:33,534,344...33,548,405
|
|
G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
increases cleavage |
ISO |
usnic acid results in increased cleavage of PARP1 protein |
CTD |
PMID:31715134 |
|
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
|
|
G |
Pdk1 |
pyruvate dehydrogenase kinase 1 |
decreases phosphorylation |
ISO |
usnic acid results in decreased phosphorylation of PDK1 protein |
CTD |
PMID:25078063 |
|
NCBI chr 3:56,705,824...56,733,040
Ensembl chr 3:56,705,871...56,733,038
|
|
G |
Por |
cytochrome p450 oxidoreductase |
multiple interactions |
ISO |
[usnic acid co-treated with Lipopolysaccharides] results in decreased expression of POR mRNA |
CTD |
PMID:22777745 |
|
NCBI chr12:20,951,058...20,999,198
Ensembl chr12:20,951,058...20,999,245
|
|
G |
Prkdc |
protein kinase, DNA-activated, catalytic subunit |
increases expression multiple interactions |
ISO |
usnic acid results in increased expression of PRKDC protein Acetylcysteine inhibits the reaction [usnic acid results in increased expression of PRKDC protein] |
CTD |
PMID:31715134 |
|
NCBI chr11:85,040,790...85,258,357
Ensembl chr11:85,040,792...85,257,952
|
|
G |
Ptgs1 |
prostaglandin-endoperoxide synthase 1 |
multiple interactions |
ISO |
[usnic acid co-treated with Lipopolysaccharides] results in decreased expression of PTGS1 mRNA |
CTD |
PMID:22777745 |
|
NCBI chr 3:19,584,015...19,605,589
Ensembl chr 3:19,584,015...19,605,586
|
|
G |
Rad50 |
RAD50 double strand break repair protein |
multiple interactions |
ISO |
[usnic acid co-treated with Lipopolysaccharides] results in decreased expression of RAD50 mRNA |
CTD |
PMID:22777745 |
|
NCBI chr10:37,809,353...37,861,309
Ensembl chr10:37,808,726...37,861,396
|
|
G |
Rps6kb1 |
ribosomal protein S6 kinase B1 |
decreases phosphorylation |
ISO |
usnic acid results in decreased phosphorylation of RPS6KB1 protein |
CTD |
PMID:25078063 |
|
NCBI chr10:71,323,777...71,367,908
Ensembl chr10:71,323,777...71,367,908
|
|
G |
Serpine1 |
serpin family E member 1 |
multiple interactions |
ISO |
[usnic acid co-treated with Lipopolysaccharides] results in decreased expression of SERPINE1 mRNA |
CTD |
PMID:22777745 |
|
NCBI chr12:19,601,272...19,611,657
Ensembl chr12:19,601,272...19,611,657
|
|
G |
Sqstm1 |
sequestosome 1 |
increases degradation |
ISO |
usnic acid results in increased degradation of SQSTM1 protein |
CTD |
PMID:25078063 |
|
NCBI chr10:34,525,517...34,536,670
Ensembl chr10:34,525,519...34,536,673
|
|
G |
Stim1 |
stromal interaction molecule 1 |
increases expression |
ISO EXP |
usnic acid results in increased expression of STIM1 protein |
CTD |
PMID:25870318 |
|
NCBI chr 1:156,656,246...156,818,777
Ensembl chr 1:156,656,013...156,818,363
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions |
ISO |
[usnic acid co-treated with Lipopolysaccharides] results in decreased expression of TNF mRNA |
CTD |
PMID:22777745 |
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Tp53 |
tumor protein p53 |
decreases expression multiple interactions increases expression |
ISO |
usnic acid results in decreased expression of TP53 protein Acetylcysteine inhibits the reaction [usnic acid results in increased expression of TP53 protein] |
CTD |
PMID:22285236 PMID:31715134 |
|
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
|
|
G |
Ugt1a5 |
UDP glucuronosyltransferase family 1 member A5 |
multiple interactions increases expression |
ISO |
[usnic acid co-treated with Lipopolysaccharides] results in increased expression of UGT1A4 mRNA usnic acid results in increased expression of UGT1A4 mRNA |
CTD |
PMID:21953288 PMID:22777745 |
|
NCBI chr 9:88,762,250...88,808,465
Ensembl chr 9:88,713,184...88,808,465
|
|
G |
Xbp1 |
X-box binding protein 1 |
increases splicing |
ISO |
usnic acid results in increased splicing of XBP1 mRNA |
CTD |
PMID:25870318 |
|
NCBI chr14:80,390,629...80,395,713
Ensembl chr14:80,390,643...80,395,693
|
|
G |
Xrcc1 |
X-ray repair cross complementing 1 |
multiple interactions |
ISO |
[usnic acid co-treated with Lipopolysaccharides] results in decreased expression of XRCC1 mRNA |
CTD |
PMID:22777745 |
|
NCBI chr 1:80,140,495...80,168,705
Ensembl chr 1:80,141,207...80,168,701
|
|